The cost-effectiveness of a behavior intervention with caregivers of patients with Alzheimer's disease

被引:84
|
作者
Nichols, Linda O. [1 ,2 ,4 ]
Chang, Cyril [3 ]
Lummus, Allan [2 ]
Burns, Robert [2 ,4 ,5 ]
Martindale-Adams, Jennifer [2 ]
Graney, Marshall J. [2 ]
Coon, David W. [6 ]
Czaja, Sara [7 ]
机构
[1] VAMC, Memphis, TN 38104 USA
[2] Univ Memphis, Dept Prevent Med, Memphis, TN 38152 USA
[3] Univ Memphis, Fogelman Coll Business & Econ, Memphis, TN 38152 USA
[4] Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA
[5] Geriatr Grp Memphis, Memphis, TN USA
[6] Arizona State Univ, Dept Psychol, Phoenix, AZ USA
[7] Univ Miami, Dept Ind Engn, Miami, FL 33152 USA
关键词
dementia; behavioral interventions; cost-effectiveness;
D O I
10.1111/j.1532-5415.2007.01569.x
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
OBJECTIVES: To examine the cost-effectiveness of a randomized, clinical trial of a home-based intervention for caregivers of people with dementia. DESIGN: This cost-effectiveness analysis examined Resources for Enhancing Alzheimer's Caregivers Health (REACH II), a multisite, randomized, clinical trial, from June 2002 through December 2004, funded by the National Institute on Aging and the National Institute of Nursing Research, of a behavioral intervention to decrease caregivers' stress and improve management of care recipient behavioral problems. SETTING: Community-dwelling dementia caregiving dyads from the Memphis REACH II site. PARTICIPANTS: Of Memphis' random sample of 55 intervention and 57 control black and white dyads, 46 in each arm completed without death or discontinuation. Family caregivers were aged 21 and older, lived with the care recipient, and had provided 4 or more hours of care per day for 6 months or longer. Care recipients were cognitively and functionally impaired. INTERVENTION( Twelve individual sessions (9 home sessions and 3 telephone sessions) supplemented by five telephone support-group sessions. Control caregivers received two "check in" phone calls. MEASUREMENTS: Incremental cost-effectiveness ratio (ICER), the additional cost to bring about one additional unit of benefit (hours per day of providing care). RESULTS: At 6 months, there was a significant difference between intervention caregivers and control caregivers in hours providing care (P = .01). The ICER showed that intervention caregivers had 1 extra hour per day not spent in caregiving, at a cost of $5 per day. CONCLUSION: The intervention provided that most scarce of caregiver commodities-time. The emotional and physical costs of dementia caregiving are enormous, and this intervention was able to alleviate some of that cost.
引用
收藏
页码:413 / 420
页数:8
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS OF DONEPEZIL IN THE TREATMENT OF PATIENTS WITH ALZHEIMER'S DISEASE: AN UPDATE
    Chyr, L. C.
    Yapici, H. O.
    Padula, W., V
    [J]. VALUE IN HEALTH, 2018, 21 : S206 - S206
  • [2] The cost-effectiveness of quetiapine for Alzheimer's disease in community dwelling patients
    Getsios, D
    Proskorovsky, I
    Caro, JJ
    O'Brien, J
    Pesa, J
    Ward, AJ
    [J]. VALUE IN HEALTH, 2005, 8 (03) : 315 - 315
  • [3] An Outline For a Cost-Effectiveness Analysis of a Drug For Patients With Alzheimer’s Disease
    Jan J.V. Busschbach
    Werner B.F. Brouwer
    Adrianus van der Donk
    Jan Passchier
    Frans F.H. Rutten
    [J]. PharmacoEconomics, 1998, 13 : 21 - 34
  • [4] An outline for a cost-effectiveness analysis of a drug for patients with Alzheimer's disease
    Busschbach, JJV
    Brouwer, WBF
    van der Donk, A
    Passchier, J
    Rutten, FFH
    [J]. PHARMACOECONOMICS, 1998, 13 (01) : 21 - 34
  • [5] Modeling cost-effectiveness of pharmaceuticals in Alzheimer's disease
    Oremus, Mark
    Tarride, Jean-Eric
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2012, 12 (03) : 275 - 277
  • [6] COST-EFFECTIVENESS OF DONEPEZIL IN ALZHEIMER'S DISEASE IN SWEDEN
    Mesterton, J.
    By, A.
    Sandelin, R.
    Jonsson, L.
    [J]. VALUE IN HEALTH, 2009, 12 (07) : A369 - A369
  • [7] COST-EFFECTIVENESS OF ADUCANUMAB VERSUS DONEPEZIL FOR PATIENTS WITH EARLY ALZHEIMER'S DISEASE
    Xiong, X.
    Li, M.
    Lu, Z. K.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S85 - S85
  • [8] Treatment of institutionalized patients with Alzheimer's disease with quetiapine: A cost-effectiveness evaluation
    Getsios, D
    O'Brien, J
    Caro, JJ
    Pesa, J
    [J]. VALUE IN HEALTH, 2005, 8 (03) : 254 - 254
  • [9] Cost-Effectiveness of the Comprehensive Interdisciplinary Program-Care in Informal Caregivers of People with Alzheimer's Disease
    Munoz-Bermejo, Laura
    Jose Gonzalez-Becerra, Maria
    Barrios-Fernandez, Sabina
    Postigo-Mota, Salvador
    Del Rocio Jerez-Barroso, Maria
    Franco Martinez, Juan Agustin
    Suarez-Lantaron, Belen
    Munoz Marin, Diego
    Martin-Bermudez, Nieves
    Ortes-Gomez, Raquel
    Gomez-Ullate-Garcia De Leon, Martin
    Martinez-Acevedo, Marta
    Rocha-Gomez, Lara
    Espejo-Antunez, Sara
    Fraile-Bravo, Mercedes
    Solis Galan, Maria Gloria
    Chato-Gonzalo, Ignacio
    Dominguez Munoz, Francisco Javier
    Angel Hernandez-Mocholi, Miguel
    Madruga-Vicente, Miguel
    Prado-Solano, Angelina
    Mendoza-Munoz, Maria
    Carlos-Vivas, Jorge
    Perez-Gomez, Jorge
    Pastor-Cisneros, Raquel
    Fuentes-Flores, Paulina
    Pereira-Payo, Damian
    De Los Rios-Calonge, Javier
    Urbano-Mairena, Javier
    Guerra-Bustamante, Joan
    Carmelo Adsuar, Jose
    [J]. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (22)
  • [10] Cost-effectiveness of screening and treating early Alzheimer's disease
    Araki, SS
    Kuntz, KM
    Neumann, PJ
    [J]. MEDICAL DECISION MAKING, 1998, 18 (04) : 456 - 456